New automated ultrasound machines make way to NY state hospitals

| | Health Imaging | Womens Imaging

A new breast cancer screening technology is being added to the list of traditional imaging technologies in New York hospitals.  

According to an Oct. 11 article by The Times Union in Albany, N.Y., new breast cancer screening tools have just been released to a handful of hospitals in New York. Albany Medical Center and Saratoga Hospital are just a couple of New York hospitals to have recently received the new technology.  

As of now, a breast screening done by an automated ultrasound machine will cost no more than a handheld ultrasound test or a mammogram, according to the article, and will provide a bigger picture in detecting and monitoring breast cancer.  

"Automated breast ultrasound machines provide doctors with a more complete image of the breast, can be completed quicker than the handheld method—which may be convenient for the patient and also lets the facility do more exams—and make the technician’s skill less of a factor in the quality of the results," according to the article.   

Having a third option for breast screenings, other than just a mammography or ultrasound, is especially revolutionary for women who have denser breasts. According to the article, 40 percent of women in the U.S. have dense breast. If they live in the state of New York, their ultrasounds are required by law to be covered by insurance. 

Read the full article below:

Via New automated ultrasound machines make way to NY state hospitals

Related Content

Is additional imaging necessary for non-enhancing asymmetries on contrast-enhanced mammograms?
Screening efforts have helped avert millions of cancer-related deaths in recent decades
New scoring system accurately predicts coronary risk in women
How does breast density affect AI accuracy?
What breast density status can tell us about cardiovascular risk
FDA clears AI software that ups cancer detection in dense breasts by 50%

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.